AbbVie Inc.
DE ˙ XTRA ˙ US00287Y1091
188,50 € ↑0,35 (0,19%)
2026-06-04
CENA AKCJI
SecurityDE:4AB / AbbVie Inc.
InstitutionNext Level Private LLC
Latest Disclosed Ownership4,230 shares
Latest Disclosed Value $ 920,084
Next Level Private LLC reports 26.08% increase in ownership of 4AB / AbbVie Inc.

On April 23, 2026 - Next Level Private LLC filed a 13F-HR form disclosing ownership of 4,230 shares of AbbVie Inc. (DE:4AB) valued at $784,242 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 7, 2026 disclosing 3,355 shares of AbbVie Inc.. This represents a change in shares of 26.08% during the quarter. The current value of the position is $797,355 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-23 2026-03-31 13F ABBVIE COM 00287Y109 4,230 875 26.08 920 20.10 0.2078
2026-01-07 2025-12-31 13F ABBVIE COM 00287Y109 3,355 81 2.47 767 1.73 0.2009
2025-10-23 2025-09-30 13F ABBVIE COM 00287Y109 3,274 50 1.55 754 25.92 0.2186
2025-07-08 2025-06-30 13F ABBVIE COM 00287Y109 3,224 261 8.81 598 -3.55 0.1948
2025-04-11 2025-03-31 13F ABBVIE COM 00287Y109 2,963 235 8.61 621 28.10 0.2313
2025-01-22 2024-12-31 13F ABBVIE COM 00287Y109 2,728 20 0.74 485 -9.36 0.1955
2024-10-10 2024-09-30 13F ABBVIE COM 00287Y109 2,708 350 14.84 535 32.18 0.2191
2024-08-02 2024-06-30 13F ABBVIE COM 00287Y109 2,358 -561 -19.22 404 -23.92 0.1850
2024-04-15 2024-03-31 13F ABBVIE COM 00287Y109 2,919 1,246 74.48 531 105.02 0.2440
2024-01-18 2023-12-31 13F ABBVIE COM 00287Y109 1,673 -54 -3.13 259 1.17 0.1469
2023-10-10 2023-09-30 13F ABBVIE COM 00287Y109 1,727 88 5.37 256 16.36 0.1698
2023-07-14 2023-06-30 13F ABBVIE COM 00287Y109 1,639 1,639 220 0.1426
2022-10-20 2022-09-30 13F ABBVIE INC COM Stock 00287Y109 0 -23,714 -100.00 0 -100.00
2022-08-09 2022-06-30 13F ABBVIE INC COM Stock 00287Y109 23,714 23,714 3,632 1.3888
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.